Short-term outcomes in patients with branch retinal vein occlusion who received intravitreal aflibercept with or without intravitreal ranibizumab

References

• KleinRMossSEMeuerSMKleinBEThe 15-year cumulative incidence of retinal vein occlusion. The Beaver Dam eye studyArch Ophthalmol200812651351818413521
   PubMed Web of Science ®Google Scholar
• US Census BureauAnnual estimates of the population by sex and five-year age groups for the United States: April 1, 2000 to July 1, 2007 NC-EST2007-01. Release Date: May 1, 2008. Available from: https://www.census.gov/prod/2008pubs/p70-117.pdfAccessed February 16, 2010
   Google Scholar
• CampochiaroPAHeierJSFeinerLBRAVO InvestigatorsRanibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III studyOphthalmology20101171102111220398941
   PubMed Web of Science ®Google Scholar
• SakanishiYLeeAUsui-OuchiAItoREbiharaNTwelve-month outcomes in patients with retinal vein occlusion treated with low-frequency intravitreal ranibizumabClin Ophthalmol2016101161116527382250
   PubMedGoogle Scholar
• CampochiaroPAWykoffCCSingerMMonthly versus as-needed ranibizumab injections in patients with retinal vein occlusion: the SHORE studyOphthalmology20141212432244225060610
   PubMed Web of Science ®Google Scholar
• BrownDMCampochiaroPABhisitkulRBSustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III studyOphthalmology20111181594160221684606
   PubMed Web of Science ®Google Scholar
• CampochiaroPASophieRPearlmanJRETAIN Study GroupLong-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN StudyOphthalmology201412120921924112944
   PubMed Web of Science ®Google Scholar
• Nghiem-BuffetSFajnkuchenFBuffetMIntravitreal ranibizumab and/or dexamethasone implant for macular edema secondary to retinal vein occlusionOphthalmologica201423221622225413000
   PubMed Web of Science ®Google Scholar
• BrynskovTKempHSørensenTLIntravitreal ranibizumab for retinal vein occlusion through 1 year in clinical practiceRetina2014341637164324646663
   PubMed Web of Science ®Google Scholar
• TanMHMcAllisterILGilliesMERandomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusionAm J Ophthalmol201415723724724112635
   PubMed Web of Science ®Google Scholar
• MylonasGSacuSDunavoelgyiRMacula Study GroupResponse of retinal sensitivity to ranibizumab treatment of macular edema after acute branch retinal vein occlusionRetina2013331220122623584689
   PubMed Web of Science ®Google Scholar
• ScottIUIpMSVanVeldhuisenPCSCORE Study Research GroupA randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6Arch Ophthalmol20091271115112819752420
   PubMed Web of Science ®Google Scholar
• IpMSScottIUVanVeldhuisenPCSCORE Study Research GroupA randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5Arch Ophthalmol20091271101111419752419
   PubMed Web of Science ®Google Scholar
• KorobelnikJFKodjikianLDelcourtCTwo-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in FranceGraefes Arch Clin Exp Ophthalmol20162542307231827286894
   PubMed Web of Science ®Google Scholar
• no authors listedArgon laser photocoagulation for macular edema in branch vein occlusion. Branch Vein Occlusion Study GroupAm J Ophthalmol1984982712826383055
   PubMed Web of Science ®Google Scholar
• NomaHFunatsuHMimuraTShimadaKMacular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusionRetina2012321844185222653545
   PubMed Web of Science ®Google Scholar
• NomaHMimuraTMacular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema secondary to central retinal vein occlusionClin Ophthalmol201261901190623204832
   PubMedGoogle Scholar
• BrownDMCampochiaroPASinghRPCRUISE InvestigatorsRanibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III studyOphthalmology20101171124113320381871
   PubMed Web of Science ®Google Scholar
• CampochiaroPABrownDMAwhCCSustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III studyOphthalmology20111182041204921715011
   PubMed Web of Science ®Google Scholar
• BergerARCruessAFAltomareFOptimal treatment of retinal vein occlusion: Canadian expert consensusOphthalmologica201523462526088287
   PubMed Web of Science ®Google Scholar
• BrownDMWykoffCCWongTPRAVE Study GroupRanibizumab in preproliferative (ischemic) central retinal vein occlusion: the rubeosis anti-VEGF (RAVE) trialRetina2014341728173524914476
   PubMed Web of Science ®Google Scholar
• OguraYRoiderJKorobelnikJFGALILEO Study GroupIntravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO studyAm J Ophthalmol20141581032103825068637
   PubMed Web of Science ®Google Scholar
• HeierJSClarkWLBoyerDSIntravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS studyOphthalmology20141211414142024679444
   PubMed Web of Science ®Google Scholar
• Lehmann-ClarkeLDiraniAMantelIAmbresinAThe effect of switching ranibizumab to aflibercept in refractory cases of macular edema secondary to ischemic central vein occlusionKlin Monbl Augenheilkd201523255255525902119
   PubMed Web of Science ®Google Scholar
• PapakostasTDLimLvan ZylTIntravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumabEye (Lond)201630798426449196
   PubMed Web of Science ®Google Scholar
• CampochiaroPAHafizGMirTAScatter photocoagulation does not reduce macular edema or treatment burden in patients with retinal vein occlusion: the RELATE trialOphthalmology20151221426143725972260
   PubMed Web of Science ®Google Scholar
• HeierJSCampochiaroPAYauLRanibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trialOphthalmology201211980280922301066
   PubMed Web of Science ®Google Scholar
• CampochiaroPAClarkWLBoyerDSIntravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT studyOphthalmology201512253854425315663
   PubMed Web of Science ®Google Scholar
• WangJKHuangTLSuPYChangPYTsengYYIntravitreal aflibercept for macular edema secondary to branch retinal vein occlusion in Chinese patientsEye Sci201530636626902063
   PubMedGoogle Scholar
• Pinheiro-CostaJCostaJMBeatoJNSwitch to aflibercept in the treatment of neovascular AMD: one-year results in clinical practiceOphthalmologica201523315516125896317
   PubMed Web of Science ®Google Scholar
• MichalewskiJNawrockiJTrębińskaMMichalewskaZSwitch to a single dose of aflibercept in bevacizumab nonresponders with AMDCan J Ophthalmol20144943143525284099
   PubMed Web of Science ®Google Scholar
• EhlkenCJungmannSBöhringerDAgostiniHTJunkerBPielenASwitch of anti-VEGF agents is an option for nonresponders in the treatment of AMDEye (Lond)20142853854524722504
   PubMed Web of Science ®Google Scholar
• EhlersJPSpirnMJShahCPRanibizumab for exudative age-related macular degeneration in eyes previously treated with alternative vascular endothelial growth factor inhibitorsOphthalmic Surg Lasers Imaging20104118218920307035
   PubMedGoogle Scholar
• MassambaNDiraniAButelNEvaluation of outer retinal tubulations in eyes switched from intravitreal ranibizumab to aflibercept for treatment of exudative age-related macular degenerationGraefes Arch Clin Exp Ophthalmol2017255616727397583
   PubMed Web of Science ®Google Scholar
• ChristopheCBronAMStraubMRetinal vein occlusions: therapeutic switch in macular oedema treatment with a 12-month follow-upOphthalmic Res20165515215826756383
   PubMed Web of Science ®Google Scholar
• YasudaMKiyoharaYArakawaSPrevalence and systemic risk factors for retinal vein occlusion in a general Japanese population: the Hisayama studyInvest Ophthalmol Vis Sci2010513205320920071683
   PubMed Web of Science ®Google Scholar
• LeeSJKohHJEffects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for exudative age-related macular degenerationOphthalmology201111810111020678805
   PubMed Web of Science ®Google Scholar